HeartHero Shocks MedTech Industry
HeartHero provides an automated and portable device that gives lifesaving-shocks to those in cardiac arrest. The Automated External Defibrillator (AED) is smaller and weighs less than the industry standard. Founder and CEO of HeartHero Gary Montague plans to make them more accessible than current AEDs, especially in the home where most cardiac arrests happen.
“I’m an Emergency Room Physician Assistant and I worked for numerous years as a medical officer for the CIA. I loved it. It was honestly my dream job and it has given me an edge. I want to continue to give back, and I get to do it with this device,” said Montague.
Physical Product Showcase
Representatives from HeartHero will be at the Physical Product Showcase at the Dairy Block on September 17 explaining how the AED works. Their goal is to broaden awareness that anyone can grab this device and save a life.
Once placed on a person’s chest, the AED analyzes heart rhythms and produces a shock if someone has lethal arrythmia, such as ventricular tachycardia or ventricular fibrillation. If the person doesn’t have an abnormal heartbeat, the AED won’t produce a shock. HeartHero’s AED notifies 911 when it is used, records the heart rhythm, and the data can be sent to the patient’s hospital. A CR123 battery provides power for the device.
HeartHero won most innovative medical device from the American College of Emergency Physicians in 2018 and from the American College of Cardiology in 2019. One of the company’s primary investors is COPIC, a Colorado medical malpractice insurance company. Montague will submit the device for FDA Class III approval by the end of the year. He plans to sell the AEDs by December of 2020 for less cost than the industry standard of $1,000 to $1,600 per unit.
“Success is going to look like someone thanking me for saving a friend or family member. Success is a life saved,” said Montague.